Lantern Pharma Inc. - LTRN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | — | A | A | 28,844.0 | 0.0 | 0.0 | 28,844.0 | View | |
| Jan 13, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Jan 13, 2026 | — | A | A | 21,152.0 | 0.0 | 0.0 | 21,152.0 | View | |
| Jan 13, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Jan 13, 2026 | — | A | A | 17,307.0 | 0.0 | 0.0 | 17,307.0 | View | |
| Jan 13, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Jan 13, 2026 | — | A | A | 18,460.0 | 0.0 | 0.0 | 18,460.0 | View | |
| Jan 13, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Jan 13, 2026 | — | A | A | 17,307.0 | 0.0 | 0.0 | 17,307.0 | View | |
| Jan 13, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Dec 22, 2025 | Chief Financial Officer | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Dec 22, 2025 | Chief Scientific Officer | A | A | 10,000.0 | 0.0 | 0.0 | 10,000.0 | View |